These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24005771)

  • 1. Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.
    Vasco C; Canazza A; Rizzo A; Mossa A; Corsini E; Silvani A; Fariselli L; Salmaggi A; Ciusani E
    J Neurooncol; 2013 Dec; 115(3):353-63. PubMed ID: 24005771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.
    Crane CA; Ahn BJ; Han SJ; Parsa AT
    Neuro Oncol; 2012 May; 14(5):584-95. PubMed ID: 22406925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4
    Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
    Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
    Fu JL; Xu DP; Shi M; Zhang H; Jin L; Tang ZR; Wang FS
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):642-5. PubMed ID: 17074148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
    Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
    PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.
    Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S
    Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
    Zhang XX; Kang XM; Zhao AM
    Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry.
    Tatura R; Zeschnigk M; Adamzik M; Probst-Kepper M; Buer J; Kehrmann J
    PLoS One; 2012; 7(11):e49962. PubMed ID: 23209626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.
    Wainwright DA; Sengupta S; Han Y; Lesniak MS
    Neuro Oncol; 2011 Dec; 13(12):1308-23. PubMed ID: 21908444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNγ+ Treg in-vivo and in-vitro represent both activated nTreg and peripherally induced aTreg and remain phenotypically stable in-vitro after removal of the stimulus.
    Daniel V; Trojan K; Adamek M; Opelz G
    BMC Immunol; 2015 Aug; 16():45. PubMed ID: 26268522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
    Panek WK; Toedebusch RG; Mclaughlin BE; Dickinson PJ; Van Dyke JE; Woolard KD; Berens ME; Lesniak MS; Sturges BK; Vernau KM; Li C; Miska J; Toedebusch CM
    J Neurooncol; 2024 Sep; 169(3):647-658. PubMed ID: 39046599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.
    Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA
    Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.